This article describes the history of melatonin's transformation, in the perception of the biomedical community, from a skin-lightening agent in amphibians to a hormone in mammals, which may also exert important behavioral-and physiological-effects in humans.
the identity of the gonad-inhibiting substance in the mammalian pineal and see whether its synthesis was suppressed when animals were exposed to environmental lighting.
Work was begun on an additional, unrelated research problem, whose resolution ultimately led to a collaboration with Dr. Julius Axelrod and a meeting with Dr. Lerner . Infusions of adrenaline were demonstrated to cause people to become anxious. Since this result seemed a clear example of the body influencing the mind, an experimental model was sought, perhaps akin to anxiety in humans, that could be used to characterize the adrenaline effect. Dr. Peter Dews had shortly before conceived of using Skinnerian conditioning techniques to explore problems in psychopharmacology: pigeons or other animals were trained to depress a key for food, and rewarded either after each n pecks or after the first peck following n minutes; they quickly learned optimal strategies for getting the most food with the smallest number of movements. Dews showed that these operant responses could be used to study effects of drugs on behavior, different classes of drugs causing characteristic changes in behavioral patterns. We showed that adrenaline did indeed have characteristic effects on behavior, that these effects were dose-related, and that the dose-response curves varied depending upon which isomer (d-vs. 1-form) was being used [9] . At about the same time, however, Axelrod presented research showing that circulating adrenaline fails to cross the blood-brain barrier [10] . (To this day it is not known why adrenaline injections altered the behavior of the pigeons.) It seemed important to apply Axelrod's neurochemical techniques, not only for studying the fate of epinephrine but also for identifying the gonad-inhibiting hormone produced by the pineal gland.
At about this time, Axelrod himself was becoming interested in the methylating enzymes [11] , including those in the pineal gland, largely because of Dr. Lerner's discovery of melatonin. Initially skeptical that there existed any enzyme in mammals capable of forming melatonin (5-methoxy-N-acetyltryptamine) from its non-methylated precursor, Axelrod had gone on to discover the particular pineal enzyme (HIOMT) that catalyzes this process [12] . We started in 1962 to work together on the identity of the pineal hormone. Initially, we set up a bioassay for the compound in pineal extracts, based on the observation that the extracts could keep the gonads from hypertrophying, and block the estrous-cycle abnormalities among rats placed under continuous illumination. We anticipated putting the pineal extracts through laborious fractionation procedures and testing the gonad-inhibiting properties of each fraction. But Axelrod proposed that we first see whether the one compound already known to be characteristic of the pineal, melatonin, might also be a gonad inhibitor. We did, and it was. Since melatonin was also known to be secreted from the pineal and taken up from the bloodstream into various organs, this finding led us to propose that it was the pineal gland's hormone [2] .
If melatonin was the elusive pineal substance that inhibited the gonads, was its synthesis or release also suppressed when animals were kept under continuous illumination? We first attempted to find out using pineals from chickens: these were relatively large and were readily available to us through a collaboration with a NASA scientist, Dr. Charles Winget. No satisfactory assay was available for measuring tissue melatonin levels, per se, so we had to assess melatonin synthesis indirectly, by measuring the activity of the melatonin-forming enzyme, HIOMT, in pineal homogenates, and hoping that nature would smile on our efforts by allowing the enzyme's activity to vary in proportion with melatonin's actual rate of synthesis in vivo. (A decade had to pass before the development of direct assays for melatonin, which would allow this assumption to be tested. Fortunately, once tested, pineal HIOMT activities and melatonin levels were found to change in parallel after various light exposures. This finding need not have been the case: it was just as likely that the methylation reaction would have been controlled by substrate or cofactor levels as by the activity of the enzyme.) Winget sent us pineals from birds exposed to light or dark for several days; we assayed their HIOMT activities, and found that the changes in melatonin formation were opposite to the way we had predicted, i.e., enzyme activity was higher in organs from chickens exposed to light [13] . We learned that a more radioactive form of ['4C]S-adenosylmethionine, the isotopically labeled cofactor used in the HIOMT assay, had just become available, making it feasible to assay the enzyme in individual pineals from rats. We repeated the light/dark study using rat organs, and found with some relief that in this species light exposure suppressed pineal HIOMT activity, and thus, in all likelihood, melatonin synthesis [14] .
Early in 1963, soon after we obtained the initial evidence that melatonin might be the gonad-inhibiting pineal hormone, Johannes Ariens-Kappers, a Dutch neuroanatomist, demonstrated that the major, and possibly sole, innervation of the rat's pineal was by postganglionic sympathetic nerves originating in the superior cervical ganglia. This suggested that the neuronal pathway through which light affected the rat's pineal might also involve the same sympathetic nerves-a relationship confirmed by removing the nerves and thereby terminating the pineal's response [15] . Similar studies using enucleated animals, or rats with selective brain lesions, subsequently showed that the photic input controlling melatonin synthesis enters the body through the eyes, and then traverses a different CNS pathway, starting with the retinohypothalamic tract, from the pathways responsible for vision [15, 16] . Pineal HIOMT activities were also shown to exhibit a sympathetically mediated daily rhythm that paralleled the 24-hour light/dark cycle. The assumption that the environmental cycle generated the rhythm [ 17] was revised after Lynch and Ralph, using the first practical melatonin assay, showed that the pineal melatonin rhythm persisted among animals kept in continuous darkness, and thus was probably of endogenous origin, and circadian, in the absence of a light/dark cycle [18] .
By 1965 it was apparent that the mammalian pineal functions as a neuroendocrine transducer, responding to nerve-type messages (norepinephrine released from its sympathetic innervation) by releasing more of a hormone (Aaron Lerner's melatonin); moreover, it was clear that the pineal had a special role in converting an external cycle (light/dark) into a "signal" that the brain could understand (that is, variations in blood or CSF melatonin levels) and could use to modulate neuroendocrine functions in rodents. This "melatonin theory" has remained the standard paradigm directing most pineal research, subsequently buttressed by such observations as those showing that (a) melatonin is an important mediator of photoperiodic changes in the hamster's testis [19] ; (b) the effectiveness of exogenous melatonin as an antigonadal agent varies markedly depending on the time of its daily injection [20] ; (c) norepinephrine accelerates melatonin's synthesis from tryptophan in vitro [21] , acting via beta receptors and cyclic AMP [22] ; (d) there are enormous daily swings in rat pineal serotonin N-acetyltransferase activity [23] ; (e) exogenous melatonin becomes concentrated within the midbrain and hypothalamus [24] and causes neurotransmitter alterations in those brain regions [25] ; (f) melatonin is antigonadal when placed in these brain loci, but not elsewhere in the brain or in the pituitary [26] ; and (g) a brain enzyme exists [27] which cleaves melatonin's indole nucleus and thereby generates what may be the locally active forms of the hormone. It would not be difficult to double the number of items in this list and still limit it to major innovations.
Probably the most compelling findings supporting the "melatonin theory" have been those obtained in the last few years from studies on human subjects. Although the earliest of these used bioassays of material extracted from body fluids (for example [28] , which demonstrated the early rhythm in human urinary melatonin), the general exploration of pineal physiology in humans really awaited the development and standardization of good radioimmunoassays [29] . These assays have now become routine in tens of laboratories; other investigators routinely assay melatonin by mass spectroscopy or high-pressure liquid chromatography. Until recently it appeared that some of the physiologic rules governing the human pineal differed from those of other animals: exposing humans to continuous illumination seemed not to suppress the daily nocturnal increase in melatonin secretion, at least over the short term. This apparent difference, however, has been shown [30] to be an artefact of experimental design: when humans are exposed at nighttime to light of ecologically adequate intensities (i.e., a tenth or more of those normally present out of doors on a cloudy day), melatonin secretion is indeed suppressed.
The critical importance of an awareness of ecological factors in designing pineal experiments now seems abundantly clear; this awareness makes it appear all the more remarkable, in retrospect, that any of the original experiments on melatonin's actions or secretion actually worked! These used a relatively insensitive species (albino rats instead of hamsters); the wrong light spectra (whatever happened to be around, instead of bulbs designed to simulate natural lighting); the wrong light intensities (animal facilities lit for humans, not for rats); gave melatonin at the wrong times of day (whenever it was convenient to do so); and, of course, were based on hypotheses about melatonin secretion derived from in vitro data about a single biosynthetic enzyme, HIOMT. Perhaps a special angel watches over scientists working in far-out fields, sometimes.
Administration of exogenous melatonin to normal human subjects causes sleepiness [31] , and even-at the proper time of day-sleep [32] . Abnormalities in melatonin secretion may also be involved-though the evidence is only conjectural, at present-in a behavioral disorder, the "Seasonal Affective Disorder Syndrome": such patients (who exhibit severe depression in the fall or winter, with typical symptoms of hypersomnia, weight gain, carbohydrate craving, and sadness [33] ), often respond favorably to "therapeutic" light intensities sufficient to suppress melatonin secretion. The hypothesis that melatonin secretion has something to do with normal sexual maturation in humans has recently been supported by the finding that the amplitude of the daily rhythm in plasma melatonin levels decreases by about 75 percent between ages seven and 15 [34] . Nocturnal levels fall from about 200 to 50 picograms/ml; daytime levels are low (5 picograms/ml) at all ages. Very large numbers of investigators now seem to be working on finding roles in humans, or even therapeutic uses, for Aaron Lerner's pineal hormone.
